Tuberculosis Prevention in the Private Sector: Using Claims-Based Methods to Identify and Evaluate Latent Tuberculosis Infection Treatment With Isoniazid Among the Commercially Insured.

ABSTRACT:

Context

Targeted identification and treatment of people with latent tuberculosis infection (LTBI) are key components of the US tuberculosis elimination strategy. Because of recent policy changes, some LTBI treatment may shift from public health departments to the private sector.

Objectives

To (1) develop methodology to estimate initiation and completion of treatment with isoniazid for LTBI using claims data, and (2) estimate treatment completion rates for isoniazid regimens from commercial insurance claims.

Methods

Medical and pharmacy claims data representing insurance-paid services rendered and prescriptions filled between January 2011 and March 2015 were analyzed.

Participants

Four million commercially insured individuals 0 to 64 years of age.

Main outcom

SUBMITTER: Stockbridge EL 

PROVIDER: S-EPMC9209323 | biostudies-literature | 2018 Jul/Aug

REPOSITORIES: biostudies-literature